Physician profile
Michael Flatley
NPI 1912990359
$829.69
in general payments reported to CMS, 2019-2025
15 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $77.26 · 2022: $15.56 · 2023: $279 · 2024: $335 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $737.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $736.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $127.04 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $126.50 | 2022-2025 | Renasys Go V2 Home, Grafix Pl, Collagenase Santyl |
| Paratek Pharmaceuticals, INC. | $103.57 | 2023-2025 | Nuzyra |
| Organogenesis INC. | $87.11 | 2023-2025 | Apligraf, Puraply |
| Bard Peripheral Vascular, INC. | $77.26 | 2021 | |
| Integra Lifesciences Corporation | $71.61 | 2024 | Tcc-Ez |
| Nevro Corp. | $67.23 | 2023-2024 | Senza |
| Eclipse Technology Solutions INC. | $31.82 | 2024 | |
| Abbott Laboratories | $23.67 | 2024 | Eterna |
| Medtronic, INC. | $23.27 | 2024 | Venaseal |
| Amgen INC. | $23.14 | 2024 | Krystexxa |
| Globus Medical, INC. | $21.24 | 2025 | Senza |
| Mimedx Group, INC. | $17.55 | 2024 | |
| Averitas Pharma INC. | $15.84 | 2023 | Qutenza |
| Bioventus LLC | $12.84 | 2023 | Exogen Ultrasound Bone Healing System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Flatley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.